Grants

At GEICO, we are deeply committed to research and the fight against gynecologic cancer.
Each year, we launch several grant calls aimed at promoting research in this field and improving the health and quality of life of our patients.

Our grants are designed to support our researchers and their multidisciplinary teams, who are working on innovative projects to better understand and treat gynecologic cancer.

If you are a researcher interested in making a difference in the lives of women affected by gynecologic cancer, we invite you to submit your project for consideration in our annual grant program.

GEICO Foundation Grant for Research in Gynecologic Tumors 2025

On the occasion of the establishment of the GEICO Foundation, we are launching the first call for the GEICO Foundation Grant for Research in Gynecologic Tumors, an initiative that reinforces our commitment to promoting scientific research in the field of gynecologic oncology.

This call aims to support original research projects that contribute to advancing knowledge in gynecologic tumors, fostering the development of new ideas, approaches, and lines of study with real impact on clinical practice and patient care.

In this edition two grants of €15.000 each will be awarded.

Interested applicants should send their application form and scientific-technical project summary by email to secretaria@grupogeico.org with a copy to epuertas@grupogeico.net indicating in the subject line: Application – “GEICO Foundation Grant 2025”.

Submission deadline: June 30, 2025, at 11:59 p.m.

All detailed information can be found in the grant guidelines, available for download below:

Download Grant Guidelines Download Application Form

GEICO Translational Research Grants “Andrés Poveda”

GEICO Translational Research Grants “Andrés Poveda” 2025

The call for applications is now open for the GEICO Translational Research Grants “Andrés Poveda” 2025, launched this year thanks to the generous donation from GSK and GEICO’s own funding.

As in previous years, this grant aims to support original research projects with a one-year duration, focused on translational research in any area of gynecologic cance.

In this edition two grants of €25.000 each will be awarded.

Interested applicants should send their application form and scientific-technical project summary by email to secretaria@grupogeico.org with a copy to epuertas@grupogeico.net
indicating in the subject line: Application – “GEICO Translational Research Grant Andrés Poveda 2025”.

Submission deadline: June 30, 2025, at 11:59 p.m.

Download Grant Guidelines Download Application Form

Grants previously awarded

2024 - GEICO 25th ANNIVERSARY Research Grant in Gynecologic Tumors

Ana Oaknin / Joan Seoane

Identification of biomarkers to predict response to Atezolizumab + Bevacizumab + chemotherapy in metastatic cervical cancer. Analysis of samples from the BEATcc trial.

2024 - GEICO 25th ANNIVERSARY Research Grant in Gynecologic Tumors

Alejandro Gallego / Antonio González

Living. Study for the comprehensive evaluation and management of needs and side effects in survivors of advanced gynecologic cancer.

2024 - GEICO Translational Research Grant “Andrés Poveda”

Rafael Moreno / Marta Gil

Mesenchymal stem cells as a cellular vehicle for an oncolytic adenovirus encoding a bi-specific T-cell activator (BsTE) against FRα for the treatment of ovarian cancer.

2024 - GEICO Translational Research Grant “Andrés Poveda”

Alfonso Cortés Salgado

Antigen expression atlas in a series of endometrial cancer cases molecularly characterized: SPECTRUM Study.

2023 - GEICO Translational Research Grant “Andrés Poveda”

Laura Costas / Jordi Ponce

Mutation analysis of circulating tumor DNA in urine samples for disease monitoring in endometrial cancer.

2023 - GEICO Translational Research Grant “Andrés Poveda”

Antonio Fernández / José Antonio López - Guerrero

Predictive study of response to immunotherapy in endometrial cancer based on complete transcriptome analysis (SERENA Study).

2022 - GEICO Translational Research Grant “Andrés Poveda”

Ainhoa Madariaga

Characterization of immune biomarkers in cervical carcinoma.

2022 - GEICO Translational Research Grant “Andrés Poveda”

Arantzazu Barquín

Prospective observational study for the development of artificial intelligence algorithms capable of predicting the evolution of patients with advanced ovarian cancer by integrating their clinical, pathological, and molecular characteristics.

2021 - GEICO Translational Research Grant “Andrés Poveda”

Alejandro Pérez - Fidalgo

Analysis of AXL and its relationship with the immune system as a mechanism of resistance to PARP inhibitors in high-grade ovarian cancer.

2021 - GEICO Translational Research Grant “Andrés Poveda”

Jordi Barretina / Margarita Romeo

Resistance to PARP inhibitors in ovarian cancer: identification of biomarkers using Single Cell technology.

2020 - GEICO Translational Research Grant “Andrés Poveda”

José Antonio López - Guerrero

Predictive model of response to DNA-damaging agents and PARP inhibitors based on genomic scarring (SCARFACE Study).

2020 - GEICO Translational Research Grant “Andrés Poveda”

Marta Mendiola / Andrés Redondo

Identification of HRD markers and short-term prediction of response to PARP inhibitors in established cell lines and patient-derived organoids in ovarian cancer.

2020 - GEICO Translational Research Grant “Andrés Poveda”

Antonio González / Beatriz Tavira

Identification of markers associated with response to PARP inhibitors and immunotherapy in recurrent ovarian cancer.